| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.008 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.009 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.01 |